In 2016, under the new situation, PHDS withstood the severe test of a new round of high-tech enterprise certification, and obtained another recognition and approval. The contents of the review by the national authority included: the area of the company (biome-pharmaceutical), core independent intellectual property rights, human resources structure, enterprise management level, R&D investment expenses, high-tech service revenue, ability to transform scientific and technological achievements, growth indicators, etc. These contents cover the multidimensional aspects of business operations. Such a rigorous investigation made PHDS grow and progress again, which turned into a positive result.

The previous round of exams has just ended and new challenges have already arrived. The next round of three years is a key stage in the development of PHDS. PHDS will continue to advance its mission in the company's established goals.